Clinical Trial Update: Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care [Phase 2]

View source ↗

Summary

A Phase 2 study sponsored by Bristol-Myers Squibb evaluated an antiviral combination for chronic hepatitis C in patients who previously failed standard of care;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED